Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 12, Issue 19_Supplement
1 October 2006
Issue Cover
ISSN 1078-0432
EISSN 1557-3265
In this Issue
Search within issue

First AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, Sep 12-15, 2006

Preclinical Studies and Early Drug Development: Target Identification, Validation, Lead Discovery, and Optimization

Diagnostic Technologies and Molecular and Cellular Profiling: Biomarkers in Early Detection and Diagnosis

Targeted Therapies and Clinical Translational Research: Determinants of Recurrence, Survival, and Response to Treatment

Diagnostic Technologies and Molecular and Cellular Profiling: Determinants of Patient Prognosis

Targeted Therapies and Clinical Translational Research: Combination Therapies

Invited Abstract (Plenary Session): Monitoring Response During Cancer Therapy

Diagnostic Technologies and Molecular and Cellular Profiling: Detection of Circulating Tumor Cells or Endothelial Cells/Progenitors

Invited Abstract (Plenary Session): Germline Determinants of Therapeutic Efficacy and Toxicity

Proffered Abstract (Plenary Session): Determinants of Patient Prognosis

Diagnostic Technologies and Molecular and Cellular Profiling: Genomics-Expression Profiling in Tumors and Model Systems

Targeted Therapies and Clinical Translational Research: Patient Selection/Stratification

Targeted Therapies and Clinical Translational Research: Drug Sensitivity and Resistance

Diagnostic Technologies and Molecular and Cellular Profiling: Biomarker Assay Development, Validation, and Qualification

Preclinical Studies and Early Drug Development: Pharmacology, Pharmacogenetics, and Pharmacogenomics

Diagnostic Technologies and Molecular and Cellular Profiling: Methylation Profiling, Epigenetics, and Chromatin Regulation

Diagnostic Technologies and Molecular and Cellular Profiling: Novel Assay Technologies

Preclinical Studies and Early Drug Development: Predicting Tumor Response to Cytotoxic Therapy

Diagnostic Technologies and Molecular and Cellular Profiling: Proteomics

Targeted Therapies and Clinical Translational Research: Optimization of Clinically Effective Dose and Schedule

Preclinical Studies and Early Drug Development: Predicting Drug Efficacy and Risk of Adverse Events

Diagnostic Technologies and Molecular and Cellular Profiling: Other Technologies

Diagnostic Technologies and Molecular and Cellular Profiling: Nanotechnology

Targeted Therapies and Clinical Translational Research: Monitoring Response to Therapy

Diagnostic Technologies and Molecular and Cellular Profiling: Functional and Molecular Imaging In Vivo and In Vitro

Targeted Therapies and Clinical Translational Research: Molecular Endpoints in Clinical Trials

Preclinical Studies and Early Drug Development: In Vitro and In Vivo Assays and Models

Proffered Abstract (Plenary Session): Monitoring Response During Cancer Therapy

Targeted Therapies and Clinical Translational Research: Clinical Pharmacology, Pharmacogenetics, and Pharmacogenomics

Proffered Abstract (Plenary Session): Successes in Developing Tumor Determinants for Targeted Therapies: Lessons Learned

Invited Abstract (Plenary Session): The Emerging Impact of Novel Preclinical Models

Targeted Therapies and Clinical Translational Research: Other Therapies

Proffered Abstract (Plenary Session): Predictive Determinants of Tumor Response to Cytotoxic Therapies

Preclinical Studies and Early Drug Development: Proof-of-Concept Studies

Targeted Therapies and Clinical Translational Research: Clinical Trial Methodology/Design

Invited Abstract (Plenary Session): Determination of Clinicially Effective Dose and Schedule

Invited Abstract (Plenary Session): Regulatory Integration of Diagnostic Markers and Therapeutic Trials

Proffered Abstract (Plenary Session): Germline Determinants of Therapeutic Efficacy and Toxicity

Invited Abstract (Plenary Session): Successes in Developing Tumor Determinants for Targeted Therapies: Lessons Learned

Invited Abstract (Keynote Address): Keynote Address

Invited Abstract (Plenary Session): Determinants of Patient Prognosis

Preclinical Studies and Early Drug Development: Other Preclinical Studies

Invited Abstract (Educational Session): Primer on New Frontiers in Diagnostic Technologies

Diagnostic Technologies and Molecular and Cellular Profiling: Bioinformatics

Invited Abstract (Plenary Session): Predictive Determinants of Tumor Response to Cytotoxic Therapies

All Issues

Advertisement

Breaking
FDA Approves Drugs for MCL, Colorectal and Breast Cancers
NCI, NIH Directors Stepping Down
Pancreatic Cancer Survival Rate Stalls
View more recent articles
Latest News
Structural Variants Increase Risk of Pediatric Cancers
South Asian Scholars Urge Action on Cancer Inequities
Greater Certainty of Survival Valued Over Speedier Drug Access
View more recent articles
Research Watch
Bile Acids Modulate T-cell Response and Function in Liver Cancer
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept